"10.1371_journal.pone.0036084","plos one","2012-04-30T00:00:00Z","Luca Morandi; Dario de Biase; Michela Visani; Valentina Cesari; Giovanna De Maglio; Stefano Pizzolitto; Annalisa Pession; Giovanni Tallini","Dipartimento di Ematologia e Scienze Oncologiche L e A Seragnoli, Sezione di Anatomia Istologia e Citologia Patologica M. Malpighi Università di Bologna-AUSL Ospedale Bellaria, Bologna, Italy; Dipartimento di Patologia Sperimentale Università di Bologna, Bologna, Italy; SOC Anatomia Patologica Azienda Ospedaliero-Universitaria Santa Maria della Misericordia, Udine, Italy","Conceived and designed the experiments: LM GT. Performed the experiments: LM DdB MV VC GDM. Analyzed the data: LM DdB MV VC GDM SP AP GT. Contributed reagents/materials/analysis tools: SP AP GT. Wrote the paper: DdB GT.","The authors have read the journals policy and have the following conflicts: LM is a consultant for Alphagenics Biotechnologies S.r.l. Two pending patents related to ASLNAqPCR were filed with the European Patent Office and are currently under review: 1) WO2011104695 (A2) 2011-09-01 for KRAS mutation detection; 2) WO2011104694 (A2) 2011-09-01 for BRAF mutation detection. Alphagenics used a very limited amount of this publicly funded grant to support the authors work by providing free of charge primers and probes. This does not alter the authors adherence to all the PLoS ONE policies on sharing data and materials.","2012","04","Luca Morandi","LM",8,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
